Kamada (KMDA) Interest & Investment Income (2012 - 2026)
Kamada's (KMDA) quarterly Interest & Investment Income came in at $425000.0 in Q1 2026, down 20.41% YoY from $534000.0 in Q1 2025, and down 3.85% on a QoQ basis from $442000.0 in Q4 2025.
Kamada (KMDA) Interest & Investment Income (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Interest & Investment Income data on file, last reported at $425000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 20.41% year-over-year to $425000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 27.09% YoY) and the FY2025 annual result came in at $1.9 million, down 9.3% from the prior year.
- Interest & Investment Income retreated to $425000.0 in Q1 2026, from $442000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $684000.0 in Q4 2024 to a low of $25.0 in Q1 2023.
- A 5-year average of $244352.4 and a median of $67000.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income tumbled 99.96% — and 2024, when it soared 1119900.0%.
- Tracing KMDA's Interest & Investment Income over 5 years: stood at $59000.0 in 2022, then surged by 740.68% to $496000.0 in 2023, then surged by 37.9% to $684000.0 in 2024, then slumped by 35.38% to $442000.0 in 2025, then decreased by 3.85% to $425000.0 in 2026.
- The last three Interest & Investment Income figures came in at $425000.0 (Q1 2026), $442000.0 (Q4 2025), and $492000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Kamada | 456.56 Mn | 427.09 Mn | 22.47 Mn | 434,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 434,000.00 |
| Mar 31, 2026 | 425,000.00 |
| Dec 31, 2025 | 442,000.00 |
| Sep 30, 2025 | 492,000.00 |
| Jun 30, 2025 | 453.00 |
| Mar 31, 2025 | 534,000.00 |
| Dec 31, 2024 | 684,000.00 |
| Sep 30, 2024 | 646,000.00 |
| Jun 30, 2024 | 508.00 |
| Mar 31, 2024 | 280,000.00 |
| Dec 31, 2023 | 496,000.00 |
| Sep 30, 2023 | 67,000.00 |
| Jun 30, 2023 | 24,975.00 |
| Mar 31, 2023 | 25.00 |
| Dec 31, 2022 | 59,000.00 |
| Sep 30, 2022 | 29.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 18,000.00 |
| Sep 30, 2021 | 68,000.00 |